Although it is possible that some positive EZH2 cancers were not detected because of potential genetic heterogeneity, we have previously shown that the usage of one tissue core per cancer is sufficient to find relevant associations between molecular alterations and tumor phenotype or patient prognosis [31, 32]. The gene discussed is EZH2; the disease is cancer.